IBD
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 17 | 0 | 1.86M | $44.10M | +1 | −1 |
| Q1 2026 | 18 | +1 | 1.96M | $46.78M | +2 | −1 |
| Q4 2025 | 17 | 0 | 1.87M | $45.13M | — | — |
| Q3 2025 | 4 | +1 | 80.58K | $1.95M | +1 | — |
| Q2 2025 | 1 | 0 | 53.30K | $1.28M | — | — |
| Q1 2025 | 1 | 0 | 50.30K | $1.19M | — | — |
| Q4 2024 | 1 | +1 | 173.99K | $4.08M | +1 | — |
| Q2 2024 | 1 | — | 76.62K | $1.79M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Goldman Sachs Group ✦ | 61.54K | — | $1.49M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 18.98K | -64.4% | $458,464 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 32 | — | $794 | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 23 | New | $567 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Fidelity (FMR) | $567 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 104 holders, 16.34M shares, $388.13M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.